Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33809641)
Watch
English
Management of hepatitis C: current and future perspectives
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
title
Management of hepatitis C: current and future perspectives
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
main subject
hepatitis C
1 reference
based on heuristic
inferred from title
author name string
Hoofnagle JH
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
publication date
1 January 1999
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
published in
Journal of Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
volume
31 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
page(s)
264-268
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
cites work
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980414-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0168-8278(99)80414-0
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
PubMed ID
10622600
1 reference
stated in
Europe PubMed Central
PubMed ID
10622600
retrieved
29 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
